Department of Otolaryngology-Head and Neck Surgery, Ascension Macomb-Oakland Hospital, Madison Heights, Michigan, USA.
Michigan Ear Institute, Farmington Hills, Michigan, USA.
Laryngoscope. 2021 Jul;131(7):E2312-E2317. doi: 10.1002/lary.29436. Epub 2021 Apr 14.
OBJECTIVES/HYPOTHESIS: Hearing rehabilitation after translabyrinthine resection of a vestibular schwannoma (VS) has largely been based on the transfer of acoustic stimulus to the contralateral ear, typically through a contralateral routing of signal hearing aid or bone-anchored hearing aid (BAHA). Cochlear implant, either as a subsequent surgery or simultaneously, has become a more common treatment option; however, there is still relatively limited data available on its success. The purpose of this study is to evaluate the early outcomes of simultaneous cochlear implantation in patients with sporadic VS undergoing translabyrinthine resection.
Prospective, nonrandomized study.
A prospective study of nonrandomized patients was completed at a tertiary care neurotology center. Audiologic outcomes, primarily based on AzBIO in quiet and background noise, as well as consonant-nucleus-consonant (CNC) testing of the affected ears were utilized. Tinnitus, dizziness, and spatial hearing questionnaries were also completed. Audiologic outcomes and questionnaires were compared between the pre- and postoperative groups.
Ten patients were included in the study with 3 month follow-up data. There was statistically significant improvement in AzBO with +10 and +5 signal to noise ratio and in quiet, as well as in CNC testing (P < .05). There was a significant improvement in Tinnitus Handicap Inventory between the two groups.
Simultaneous cochlear implantation is a viable treatment for hearing loss after translabyrinthine approach to VS. These patients have improved hearing in background noise and tinnitus compared to their preoperative state. Further prognostic data are required to determine which patients are the best candidates.
4 Laryngoscope, 131:E2312-E2317, 2021.
目的/假设:经迷路切除前庭神经鞘瘤(VS)后的听力康复在很大程度上基于将声刺激转移到对侧耳,通常通过对侧信号听力辅助器或骨锚式听力辅助器(BAHA)进行。耳蜗植入,无论是作为后续手术还是同时进行,已成为更常见的治疗选择;然而,关于其成功的相关数据仍然相对有限。本研究的目的是评估经迷路切除后接受同时耳蜗植入的散发性 VS 患者的早期结果。
前瞻性、非随机研究。
在三级神经耳科中心完成了一项非随机患者的前瞻性研究。使用安静和背景噪声中的 AzBIO 以及受影响耳朵的辅音核辅音(CNC)测试主要评估听力结果。还完成了耳鸣、头晕和空间听力问卷调查。比较了术前和术后组的听力结果和问卷。
该研究纳入了 10 名患者,其中 3 个月的随访数据。在+10 和+5 信噪比以及安静环境中的 AzBO 以及 CNC 测试中,听力均有统计学显著改善(P<.05)。两组之间的耳鸣残疾量表(Tinnitus Handicap Inventory)有显著改善。
经迷路入路切除 VS 后,同时进行耳蜗植入是治疗听力损失的可行方法。与术前相比,这些患者在背景噪声和耳鸣方面的听力有所提高。需要进一步的预后数据来确定哪些患者是最佳候选者。
4 Laryngoscope,131:E2312-E2317,2021 年。